Studies have revealed that RNF5 silencing increases tumor suppressor p53 levels in breast cancer cells [18], and RNF5 KO cells exhibited a decreased cell cycle progression (Fig 1C); thus, we investigated whether the expression of p53 and cell cycle genes were affected in RNF5 KO cells. The gene discussed is TP53; the disease is breast carcinoma.